Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

计划入组 120 人 · 首次发布于 2025 年 10 月 22 日

Otago Exercises and Otago Exercise Effects on Elderly Population

计划入组 44 人 · 首次发布于 2024 年 1 月 5 日

Alpena Otago Telehealth Program

计划入组 23 人 · 首次发布于 2020 年 12 月 11 日

OraPro-Zika (iosBio)

OraPro-Flu (iosBio)

OraPro-COVID-19 ( iosBio)

UNIVERSITY OF OTAGO

New Zealand

Napo Pharmaceuticals, Inc.

United States

FDA Approves Supernus' ONAPGO for Motor Fluctuations in Advanced Parkinson's Disease

Supernus Pharmaceuticals Acquires Sage Therapeutics for Up to $795 Million, Securing Postpartum Depression Drug Zurzuvae

Supernus Pharmaceuticals Acquires Sage Therapeutics for $795 Million, Strengthening Neuropsychiatry Portfolio